# Use of Exhaled Carbon Dioxyde for Monitoring the Native Cardiac Function During Mechanical Circulatory Support With Venoarterial By-pass in Intensive Care Unit

> **NCT03323268** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 39 (actual)

## Conditions studied

- Residual Cardiac Output During PVA-ECMO

## Interventions

- **DEVICE:** PetCO2 monitoring

## Key facts

- **NCT ID:** NCT03323268
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-12
- **Primary completion:** 2016-10-23
- **Final completion:** 2017-10-23
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03323268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03323268, "Use of Exhaled Carbon Dioxyde for Monitoring the Native Cardiac Function During Mechanical Circulatory Support With Venoarterial By-pass in Intensive Care Unit". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03323268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*